Saga Q1 2026 Earnings Negative EPS and Stock Decline Amidst Industry Headwinds PBYI Q1 2026 Earnings NarrowerThanExpected Loss Signals Operational Discipline LILAK Q1 2026 Earnings Deep EPS Miss Highlights Persistent Headwinds EYPT Q1 2026 Earnings EPS Misses Estimates as Clinicalstage Biotech Advances Pipeline OBIO Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline in PreRevenue Phase CWST Q1 2026 Earnings Strong Earnings Beat Drives Modest Share Price Uptick